Purdue University
West Lafayette, Indiana, 47907, United States
NCT Number: NCT01886326
Evidence is accumulating that peanut consumption confers health benefits, such as reduction of cardiovascular disease risk and possibly diabetes risk (Jenkins et al., 2008; Mattes et al., 2008). However, peanuts are a high fat, energy dense food and concerns about weight gain are widespread. Although research indicates that other characteristics of peanuts offset these properties, and that peanuts may be incorporated into diets without posing a threat to weight gain (Mattes et al., 2008), concern remains among policymakers, healthcare providers, and consumers. Furthermore, worry exists that eating salted peanuts may elevate blood pressure and that eating honey-roasted peanuts make elevate blood sugar. These fears create substantial obstacles to increased peanut consumption.
Recommendations to increase peanut consumption may be made, but if they are not followed, there will be no impact on health. Additional knowledge is needed on: (1) the acceptability of peanuts consumed on a chronic basis, (2) the chronic intake of moderate levels of peanuts and body weight, and 3) the effects of peanuts on blood pressure and blood sugar. The proposed research will examine the acceptability of long-term inclusion of a single form versus varied forms of peanuts in the diet. It is expected that responses will be varied among individuals with different personality characteristics (e.g., prefer sweet versus savory foods, hedonic versus non-hedonic eaters). A better understanding of how different segments of the population choose to include peanuts in their diet and how to optimize long-term consumption should provide insights for better marketing and improved health. Furthermore, it is anticipated that eating salty peanuts will not raise blood pressure and that eating honey-roasted peanuts will not raise blood sugar. Documenting this will add credibility to the evidence that peanuts do not cause weight gain, as well as reinforce recommendations to increase peanut consumption for their health benefits.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
West Lafayette, Indiana, 47907, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Consumption of the given 42 grams of peanuts daily without instructions for use (i.e. with/without meals, etc.)
Time frame: 2, 4, 6, 8, 10, and 12 weeks
Time frame: 4, 8, and 12 weeks
Time frame: 2, 4, 6, 8, 10, and 12 weeks
Time frame: 12 weeks
Participants will rate their liking of the sample each day using a visual analog scale.
Time frame: 2, 4, 6, 8, 10, and 12 weeks
Time frame: 4, 8, and 12 weeks
Time frame: 4, 8, and 12 weeks
Time frame: 4, 8, and 12 weeks
Time frame: 2, 4, 6, 8, 10, and 12 weeks
Time frame: At baseline visit
Time frame: At baseline
Time frame: 12 weeks
Participants will self-report compliance to study protocol using record sheets.
Time frame: 4, 8, and 12 weeks
Collected on handheld computer
Time frame: 12 weeks
Participants will note if peanuts were eaten as a meal or snack, at what time, and with what other foods daily.
Purdue University
Other
Peanut Consumption and Human Weight Management
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02991534
Body Weight, Cardiovascular Diseases
Sepulveda, California, United States
View Trial DetailsNCT01326442
Body Weight, Body Weight Changes
Guelph, Ontario, Canada
View Trial DetailsNCT07662616
Body Weight, Cardiovascular Diseases
View Trial DetailsNCT05874726
Apnea, Body Weight
Boston, Massachusetts, United States
View Trial Details